PUBLICATION
Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
- Authors
- Ren, J., Liu, S., Cui, C., Ten Dijke, P.
- ID
- ZDB-PUB-170519-6
- Date
- 2017
- Source
- Journal of visualized experiments : JoVE (122): e55459 (Journal)
- Registered Authors
- Keywords
- none
- MeSH Terms
-
- Animals
- Animals, Genetically Modified*
- Breast Neoplasms/blood supply*
- Cell Line, Tumor
- Disease Models, Animal*
- Female
- Humans
- Neovascularization, Pathologic
- Xenograft Model Antitumor Assays/methods*
- Zebrafish/embryology
- Zebrafish/genetics*
- PubMed
- 28518096 Full text @ J. Vis. Exp.
Citation
Ren, J., Liu, S., Cui, C., Ten Dijke, P. (2017) Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish. Journal of visualized experiments : JoVE. (122):e55459.
Abstract
In many cases, cancer patients do not die of a primary tumor, but rather because of metastasis. Although numerous rodent models are available for studying cancer metastasis in vivo, other efficient, reliable, low-cost models are needed to quickly access the potential effects of (epi)genetic changes or pharmacological compounds. As such, we illustrate and explain the feasibility of xenograft models using human breast cancer cells injected into zebrafish embryos to support this goal. Under the microscope, fluorescent proteins or chemically labeled human breast cancer cells are transplanted into transgenic zebrafish embryos, Tg (fli:EGFP), at the perivitelline space or duct of Cuvier (Doc) 48 h after fertilization. Shortly afterwards, the temporal-spatial process of cancer cell invasion, dissemination, and metastasis in the living fish body is visualized under a fluorescent microscope. The models using different injection sites, i.e., perivitelline space or Doc are complementary to one another, reflecting the early stage (intravasation step) and late stage (extravasation step) of the multistep metastatic cascade of events. Moreover, peritumoral and intratumoral angiogenesis can be observed with the injection into the perivitelline space. The entire experimental period is no more than 8 days. These two models combine cell labeling, micro-transplantation, and fluorescence imaging techniques, enabling the rapid evaluation of cancer metastasis in response to genetic and pharmacological manipulations.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping